Last edition
News about "Syngene International Ltd., a Bengaluru-based inte"
Syngene Reports 14.5% YoY Growth in Q1 Net Profit, Driven by Strong Research Services Momentum
Operational revenue grew by 10.7% to INR 874.5 crore from INR 789.7 crore in Q1 FY25. EBITDA for the quarter rose 19% to INR 224 crore, compared to INR 188 crore last year. The EBITDA margin improved to 25%, up from 23% a year ago.
Syngene International Ltd., A Bengaluru-based Inte | 24/07/2025 | By Darshana | 285
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members